HealthSouth Corporation (HLS) Issues FY17 Earnings Guidance

Paterniano Del Favero
Agosto 13, 2017

HealthSouth Corporation makes up about 5.6% of Cumberland Partners Ltd's holdings, making the stock its largest position. Washington Capital Management Inc.'s holdings in HealthSouth Corporation were worth $518,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of the company. World Asset Management Inc increased its stake in shares of HealthSouth Corporation by 0.8% in the first quarter. Bank of New York Mellon Corp increased its stake in HealthSouth Corporation by 1.6% in the second quarter.

The company is trading down by -0.02 percent from yesterday's close. Investment Centers Of America Inc controls 99,261 shares worth $4,805,000.

Martingale Asset Management L P augmented its ownership by buying 14 shares an increase of 0.0% in the quarter. Neuburgh Advisers LLC raised its position in shares of HealthSouth Corporation by 40.1% in the first quarter. The value of the investment in (HLS) went from $6,544,000 to $9,087,000 a change of $2,543,000 since the last quarter. As of quarter end Alliancebernstein L.P. had acquired 34,890 shares growing its stake by 22.8%. Principal Financial Group Inc. now owns 1,147,210 shares of the company's stock worth $55,524,000 after buying an additional 105,681 shares during the period. Hedge funds and other institutional investors own 97.96% of the company's stock.

Healthsouth Corp (NYSE:HLS) institutional sentiment increased to 2.02 in 2016 Q4. The firm's stock has a market capitalization of $3.9 bln. HealthSouth Corporation has a 52-week low of $36.97 and a 52-week high of $49.71. The company has a 50-day moving average price of $45.71 and a 200 day moving average price of $44.16. The stock of HealthSouth Corp (NYSE:HLS) earned "Outperform" rating by RBC Capital Markets on Monday, October 31. The company reported $0.71 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.68 by $0.03.

HealthSouth Corporation (HLS) stock marked a gap of -12.23% off its 52 week- peak price value and pointed turn of 18.01% from its 52 week-bottom price value. The firm had revenue of $981.30 million for the quarter, compared to the consensus estimate of $976.46 million. The Q4 2017 consensus earnings estimates for the company have stabilized at US$0.65 per share. HealthSouth Corporation's revenue was up 6.6% on a year-over-year basis. Equities research analysts predict that HealthSouth Corporation will post $2.71 EPS for the current fiscal year. Stockholders of record on Monday, October 2nd will be paid a dividend of $0.25 per share. The value of the total investment in HealthSouth Corporation increased from $796,000 to $892,000 a change of $96,000 quarter to quarter. The ex-dividend date is set for Thursday the 29th of June 2017. This represents a $1.00 annualized dividend and a yield of 2.34%. HealthSouth Corporation's dividend payout ratio (DPR) is presently 35.29%.

TRADEMARK VIOLATION WARNING: This news story was reported by Community Financial News and is owned by of Community Financial News. If you are reading this piece on another site, it was stolen and republished in violation of US and global copyright & trademark laws. HLS was included in 22 notes of analysts from July 31, 2015. ValuEngine lowered HealthSouth Corporation from a buy rating to a hold rating in a research note on Friday, June 2nd. Mizuho maintained the shares of HLS in report on Monday, July 10 with "Neutral" rating. Barclays PLC reiterated an "underweight" rating and set a $46.00 price target (up from $44.00) on shares of HealthSouth Corporation in a research report on Monday, May 1st. Zacks Investment Research lowered shares of HealthSouth Corporation from a "hold" rating to a "sell" rating in a research report on Tuesday, April 25th. Citigroup Inc. had 78 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has an average rating of "Hold" and an average price target of $48.83. The stock was sold at an average price of $42.55, for a total transaction of $962,693.75.

In related news, CEO Mark J. Tarr sold 22,625 shares of the stock in a transaction dated Thursday, August 3rd. Tarr let go of 22,625 shares at an average price of $43.00 on Monday the 7th. Following the completion of the sale, the chief executive officer now directly owns 283,134 shares in the company, valued at approximately $12,174,762. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Firm manages its activities through divisions, including inpatient rehabilitation, and home health and hospice. Price T Rowe Associate Md holds 0.01% or 963,092 shares in its portfolio.

Altre relazioni OverNewsmagazine

Discuti questo articolo